Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

BIOFRONTERA INC.

(BFRI)
  Report
Delayed Nasdaq  -  03:59 2022-10-06 pm EDT
1.130 USD   +1.80%
10/05Biofrontera Reports Preliminary Q3 Product Revenue -- Stock Down 7% After-Hours
MT
10/05Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022
GL
10/05Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Biofrontera's Management, Supervisory Boards Recommend Shareholders Reject Deutsche Balaton's Acquisition Offer

08/01/2022 | 12:25pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
BIOFRONTERA AG 7.33% 1.61 Delayed Quote.8.78%
BIOFRONTERA INC. 1.80% 1.13 Delayed Quote.-85.24%
All news about BIOFRONTERA INC.
10/05Biofrontera Reports Preliminary Q3 Product Revenue -- Stock Down 7% After-Hours
MT
10/05Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022
GL
10/05Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022
AQ
09/29Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference
GL
09/29Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference
AQ
09/27Biofrontera Inc. Marketing Campaign and Website for Ameluz Won 2022 PM360 Trailblazer A..
AQ
09/26Biofrontera Inc.'s Marketing Campaign and Website for Ameluz Won 2022 PM360 Trailblazer..
GL
09/26Biofrontera Inc.'s Marketing Campaign and Website for Ameluz Won 2022 PM360 Trailblazer..
AQ
09/13Biofrontera Inc. Names Gerard DiGirolamo as National Sales Director
GL
09/13Biofrontera Inc. Names Gerard DiGirolamo as National Sales Director
AQ
More news
Analyst Recommendations on BIOFRONTERA INC.
More recommendations
Financials (USD)
Sales 2022 31,9 M - -
Net income 2022 -3,71 M - -
Net Debt 2022 - - -
P/E ratio 2022 -6,46x
Yield 2022 -
Capitalization 26,6 M 26,6 M -
Capi. / Sales 2022 0,84x
Capi. / Sales 2023 0,59x
Nbr of Employees 69
Free-Float 65,3%
Chart BIOFRONTERA INC.
Duration : Period :
Biofrontera Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOFRONTERA INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 1,13 $
Average target price 15,50 $
Spread / Average Target 1 272%
EPS Revisions
Managers and Directors
Erica L. Monaco Chief Executive, Operating & Financial Officer
Erica Gates Controller, CAO & Senior Director-Finance
Hermann Lübbert Executive Chairman
Armin Ollig Vice President-Information Technology
Daniel Hakansson General Counsel & Head-Compliance
Sector and Competitors
1st jan.Capi. (M$)
BIOFRONTERA INC.-85.24%26
JOHNSON & JOHNSON-5.35%434 104
ELI LILLY AND COMPANY20.11%315 249
ROCHE HOLDING AG-13.48%273 724
ABBVIE INC.5.86%253 421
PFIZER, INC.-27.03%247 617